Navigation Links
Regional Biotech Association Urges Support for Biosimilars Bill in Congress
Date:9/22/2009

BOSTON, Sept. 22 /PRNewswire/ -- A vast coalition of New England business leaders today joined the New England Biotech Association (NEBA) to push for Congress to approve a legislative pathway for biosimilars that protect patient safety but also provide sufficient incentives for new innovative products to be developed.

NEBA and 27 other organizations and biotechnology leaders across New England said in a letter to all members of the New England congressional delegation that the biosimilars legislation is the single biggest issue in protecting the future viability and growth of New England's biotechnology industry: "New biologic medicines represent the greatest hope for treating diseases such as cancer, asthma, Parkinson's, and Alzheimers. It is crucial that biosimilars legislation preserve the incentives necessary for biotech researchers to develop the next breakthrough medical treatments. These incentives should include an appropriate period of 12-years of data exclusivity to allow New England's biotech companies to attract and protect the massive investment necessary to develop a biologic."

During its recent consideration of health care reform legislation, both the Senate Health, Education, Labor and Pensions (HELP) Committee and the House Energy and Commerce Committee adopted bipartisan amendments that provide a safe, effective and reasonable pathway for the approval of biosimilars. These amendments, approved by overwhelmingly bipartisan votes, strike the right balance between expanding competition to lower costs for consumers and preserving incentives for continued biomedical innovation by providing a 12-year period of data exclusivity.

If the final legislation approved by Congress does not protect patient safety and provide sufficient incentives for investment in innovative new biologic medicines, it would deliver a devastating blow to the hope held by millions of patients and seriously undermine the region's biotech sector."

As the regional policy and public affairs voice for the biotechnology and biopharmaceutical community, NEBA represents state biotech associations, companies, academic institutions, and other organizations from all six New England states.

To find out more about NEBA, visit www.newenglandbiotech.org


'/>"/>
SOURCE New England Biotech Association
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
2. A Magnetic Gift: Sumter Regional Hospital Receives New MRI as Charitable Donation From Siemens
3. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
4. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
5. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
6. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
7. China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
8. New Regional Biotech Association Formed
9. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission
10. Regional Biotech Association Warns Vermont Legislation Could Have Profound Negative Impact
11. Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... ... for the improvement of crop productivity and economics for the food, feed and ... scope of the agreement includes the research and development of microbiome-based seed treatments ...
(Date:7/25/2017)... , ... July 25, 2017 ... ... to welcome Chuck Heinz as Executive Director of Strategic Planning. His extensive ... Benchworks team. , Chuck’s professional experience encompasses marketing and differentiation consulting, business ...
(Date:7/24/2017)... 2017 Intralytix, Inc. announced that it received ... French family group. This investment marks the beginning of ... commercialize bacteriophage-based products, for various benefits in human health ... As a global key ... markets innovative solutions for baking, food taste & pleasure, ...
(Date:7/20/2017)... ... July 20, 2017 , ... The Arnold and ... Thomson Professor of Electrical Engineering and Computer Science at the Massachusetts Institute of ... the award recognizes an individual who has made and is continuing to make ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017   Bridge Patient ... organizations, and MD EMR Systems , an ... partner for GE, have established a partnership to ... product and the GE Centricity™ products, including Centricity ... These new integrations will allow ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... Annual Report on Form 10-K on Thursday April 13, 2017 with ... ... Relations section of the Company,s website at http://www.nxt-id.com  under "SEC ... . 2016 Year Highlights: Acquisition ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
Breaking Biology News(10 mins):